Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens
Niclas Olsson, Marlene L. Heberling, Lichao Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25

Showing 25 citing articles:

The impact of immunopeptidomics: From basic research to clinical implementation
Ilja E. Shapiro, Michal Bassani‐Sternberg
Seminars in Immunology (2023) Vol. 66, pp. 101727-101727
Open Access | Times Cited: 47
Thunder-DDA-PASEF enables high-coverage immunopeptidomics and is boosted by MS2Rescore with MS2PIP timsTOF fragmentation prediction model
David Gomez‐Zepeda, Danielle Arnold-Schild, Julian Beyrle, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Functional Differences between Proteasome Subtypes
Joanna Abi Habib, Julie Lesenfants, Nathalie Vigneron, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 421-421
Open Access | Times Cited: 55
Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues
Jennifer G. Abelin, Erik J. Bergstrom, Keith Rivera, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 37
Engineering neoantigen vaccines to improve cancer personalized immunotherapy
Zaoqu Liu, Jinxiang Lv, Qin Dang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5607-5623
Open Access | Times Cited: 27
Hypoxia promotes tumor immune evasion by suppressing MHC-I expression and antigen presentation
Hala Estephan, Arun Tailor, Robert Parker, et al.
The EMBO Journal (2025) Vol. 44, Iss. 3, pp. 903-922
Open Access
SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells
Melissa Bernhardt, Anne Rech, Marion Berthold, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Antigen discovery for the development of cancer immunotherapy
Ryuhjin Ahn, Yufei Cui, Forest M. White
Seminars in Immunology (2023) Vol. 66, pp. 101733-101733
Open Access | Times Cited: 12
At the Cutting Edge against Cancer: A Perspective on Immunoproteasome and Immune Checkpoints Modulation as a Potential Therapeutic Intervention
Grazia R. Tundo, Diego Sbardella, Francesco Oddone, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4852-4852
Open Access | Times Cited: 19
Tuning DO:DM Ratios Modulates MHC Class II Immunopeptidomes
Niclas Olsson, Wei Jiang, Lital N. Adler, et al.
Molecular & Cellular Proteomics (2022) Vol. 21, Iss. 3, pp. 100204-100204
Open Access | Times Cited: 13
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
Belén Aparicio, Patrick Theunissen, Sandra Hervás‐Stubbs, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
The Effect of Interferons on Presentation of Defective Ribosomal Products as HLA Peptides
Liran Komov, Dganit Melamed Kadosh, Eilon Barnea, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100105-100105
Open Access | Times Cited: 14
HLA class II immunopeptidomics reveals that co‐inherited HLA‐allotypes within an extended haplotype can improve proteome coverage for immunosurveillance
Sri H. Ramarathinam, Bosco Ho, Nadine L. Dudek, et al.
PROTEOMICS (2021) Vol. 21, Iss. 17-18
Closed Access | Times Cited: 14
COSMIC-based mutation database enhances identification efficiency of HLA-I immunopeptidome
Fangzhou Wang, Zhenpeng Zhang, Mingsong Mao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
MONTE enables serial immunopeptidome, ubiquitylome, proteome, phosphoproteome, acetylome analyses of sample-limited tissues
Jennifer G. Abelin, Erik J. Bergstrom, Hannah B. Taylor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10
New insights and approaches for analyses of immunopeptidomes
Patricia T. Illing, Sri H. Ramarathinam, Anthony W. Purcell
Current Opinion in Immunology (2022) Vol. 77, pp. 102216-102216
Closed Access | Times Cited: 6
Soluble HLA peptidome: A new resource for cancer biomarkers
Erwin Tanuwidjaya, Ralf B. Schittenhelm, Pouya Faridi
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Immunogenomic Biomarkers and Validation in Lynch Syndrome
Ramadhani Chambuso, Mbali Mthembu, Evelyn Kaambo, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 491-491
Open Access | Times Cited: 3
Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγ
Alice Newey, Lu Yu, Louise J. Barber, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 11, pp. 2345-2357
Open Access | Times Cited: 3
Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity
Beatrice Thier, Fang Zhao, Simone Stupia, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e003863-e003863
Open Access | Times Cited: 5
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint
Hsiao‐Wei Tsao, Seth Anderson, Kenneth J. Finn, et al.
Immunity (2024)
Open Access
Birinapant Reshapes the Tumor Immunopeptidome and Enhances Antigen Presentation
Weiyan Zhang, Shenghuan Sun, Wen‐Yuan Zhu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3660-3660
Open Access
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma
Tongji Xie, Guangyu Fan, Liling Huang, et al.
Epigenomics (2022) Vol. 14, Iss. 22, pp. 1427-1448
Closed Access | Times Cited: 2
Proteomics in support of immunotherapy: contribution to model-based precision medicine
Emmanuel Nony, Philippe Moingeon
Expert Review of Proteomics (2021) Vol. 19, Iss. 1, pp. 33-42
Closed Access | Times Cited: 1
COSMIC-based mutation database enhances identification efficiency of HLA-I immunopeptidome
Fangzhou Wang, Zhenpeng Zhang, Mingsong Mao, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top